Who controls Google's AI Overview for Luxury Medical Aesthetic Clinics Seoul?

Source: https://theobservatory.io/articles/aesthetic-clinics-seoul-ai-overview-control-september-7-13-2026
Scope: Luxury Medical Aesthetic Clinics Seoul · Seoul · AI Overview · Google · Desktop
Family: Ranking Top 10
Observed: September 7–13, 2026 (2026-09-07/2026-09-13)
Published: September 15, 2026
Method — How readings are scoped: https://theobservatory.io/method#standards
Method — Run metadata: https://theobservatory.io/method/panel#run-metadata
Method — Source protocol: https://theobservatory.io/method#source-protocol
Method — Corrections and right of reply: https://theobservatory.io/method#corrections
Public table: https://theobservatory.io/articles/aesthetic-clinics-seoul-ai-overview-control-september-7-13-2026/data.csv
Citation text: https://theobservatory.io/articles/aesthetic-clinics-seoul-ai-overview-control-september-7-13-2026/citation.txt
Reuse terms: https://theobservatory.io/terms

Across the 6-run window from September 7–13, 2026, us-uk.bookimed.com holds the strongest AI opening share on the Luxury Medical Aesthetic Clinics Seoul market at 15.50%, leading a top-10 panel drawn from 80 observed queries on Google desktop in South Korea.

Key facts:
• us-uk.bookimed.com: 16% AI opening share · opening in 6/6 runs
• reddit.com: 10% AI opening share · opening in 6/6 runs
• seoulskinclinicforforeigners.com: 10% AI opening share · opening in 6/6 runs

Published table — AIO opening control — top 10 (September 7–13, 2026 · 80 queries per run · 6 comparable runs): Rank · Actor · AIO opening control
1. us-uk.bookimed.com — 15.50% AI opening share · opening in 6/6 runs — #1
2. reddit.com — 10.47% AI opening share · opening in 6/6 runs — #2
3. seoulskinclinicforforeigners.com — 10.08% AI opening share · opening in 6/6 runs — #3
4. seoulcosmeticsurgery.com — 9.69% AI opening share · opening in 6/6 runs — #4
5. youtube.com — 8.14% AI opening share · opening in 5/6 runs — #5
6. enlienjang.com — 6.59% AI opening share · opening in 6/6 runs — #6
7. creatrip.com — 6.20% AI opening share · opening in 6/6 runs — #7
8. pmc.ncbi.nlm.nih.gov — 5.81% AI opening share · opening in 5/6 runs — #8
9. forenaclinic.com — 5.43% AI opening share · opening in 6/6 runs — #9
10. medicaltravelkorea.com — 4.65% AI opening share · opening in 4/6 runs — #10

Reading basis: This card observes the AI Overview opening-control rail for Luxury Medical Aesthetic Clinics Seoul in South Korea on Google desktop across 6 comparable scheduled runs in the observation period September 7–13, 2026. The panel ranks the top-10 actors by cumulative AI opening volume over the period, aggregated from 80 observed queries. The primary metric is AI opening share on this market. AI Overview opening-control evidence was available on 6 of 6 runs in the comparable window.

Limitations and non-claims:
— Observes the observed AI answer surface only; within a defined scope and window.
— A period aggregate (6 comparable runs) — not a claim about bookings, revenue, or market share.
— Scoped to Luxury Medical Aesthetic Clinics Seoul Seoul, September 2026; not generalisable beyond this market and window.

— The Observatory · Luxury Medical Aesthetic Clinics Seoul · Seoul · AI Overview · Google · Desktop · September 7–13, 2026
Based on governed AAI Kernel evidence. Capture identifier: pr_1791394036156_bu0hoi. Cite freely with attribution. Published by The Observatory.
Source footnote: Sourced from a published AAI MIB card. The Observatory publishes this card’s public findings; values are as observed on the search surface, not business-market claims.
Attribution: Published by The Observatory · Based on an AAI Kernel capture · governed by The Observatory editorial system
Cite: According to The Observatory (September 15, 2026), Who controls Google's AI Overview for Luxury Medical Aesthetic Clinics Seoul?. https://theobservatory.io/articles/aesthetic-clinics-seoul-ai-overview-control-september-7-13-2026

This record is the published reading and its public table/slice as served on the card — not the complete underlying capture or provider dataset.
Observed by The Observatory. Not an endorsement, recommendation, market-share claim or commercial ranking.
Free reuse, including commercial republication, under The Observatory’s Terms. Retain attribution, source link, scope and date.
Revision: 4cc751e9812f24ff